Healthpeak Q3 2022 Earnings Report
Key Takeaways
Healthpeak Properties reported a net income of $0.65 per share, Nareit FFO of $0.42 per share, and FFO as Adjusted of $0.43 per share. The blended Total Same-Store Portfolio Cash (Adjusted) NOI growth was 5.1%. They are increasing full-year 2022 FFO as Adjusted and Total Portfolio Same-Store Cash (Adjusted) NOI growth guidance.
Net income of $0.65 per share, Nareit FFO of $0.42 per share, FFO as Adjusted of $0.43 per share, and blended Total Same-Store Portfolio Cash (Adjusted) NOI growth of 5.1%.
Life Science and MOB Same-Store Portfolio Cash (Adjusted) NOI growth of 5.4% and 4.9%, respectively
Third quarter life science lease executions totaled over 500,000 square feet
Net debt to adjusted EBITDAre and liquidity were 5.3x and $2.4 billion, respectively, as of September 30, 2022
Healthpeak
Healthpeak
Forward Guidance
We are updating the following guidance ranges for full year 2022:
Positive Outlook
- Diluted FFO as Adjusted per share from $1.68 – $1.74 to $1.72 – $1.74
- Total Portfolio Same-Store Cash (Adjusted) NOI growth Guidance from 3.50% – 5.00% to 4.50% – 5.50%
Challenges Ahead
- Diluted earnings per common share from $0.97 – $1.03 to $0.94 – $0.96
- Diluted Nareit FFO share from $1.70 – $1.76 to $1.67 – $1.69